Huiyuan Jiang1, Xin Cheng2, Yanjie Liang3, Yan Wang4, Yiqun Li5, Yaoping Li6. 1. Department of Colorectal & Anal Surgery, Affiliated Tumor Hospital of Shanxi Medical University, Taiyuan, China. 2. Department of Gynecology, First Affiliated Hospital of Shanxi Medical University, Taiyuan, China. 3. Department of Laboratory Medicine, Affiliated Tumor Hospital of Shanxi Medical University, Taiyuan, China. 4. Department of Aetiology, Affiliated Tumor Hospital of Shanxi Medical University, Taiyuan, China. 5. Department of Colorectal & Anal Surgery, Affiliated People's Hospital of Shanxi Medical University, 29 Shuangtasi Street, Taiyuan, 030012, China. 6. Department of Colorectal & Anal Surgery, Affiliated People's Hospital of Shanxi Medical University, 29 Shuangtasi Street, Taiyuan, 030012, China. liyaoping1600@Sina.com.
Abstract
BACKGROUNDS: WNK1 (WNK lysine deficient protein kinase 1) is a kind of protein kinase and participates in angiogenesis, having a potent tumor promoting role. WNK1 is ubiquitously expressed, and its upregulated expression has been reported in several tumor types. AIMS: Here, we aimed to investigate the correlation between WNK1 expression and colon adenocarcinoma (COAD) progression. METHODS: In the current study, WNK1 expression was evaluated by immunohistochemically in adjacent normal colonic mucosae and primary adenocarcinomas. The effect of WNK1 on overall survival (OS) and its associations with the clinicopathological parameters were analyzed in a retrospective cohort of COAD patients (n = 185). The tumor-related effects of WNK1 in COAD were further tested via cellular and mice experiments. RESULTS: According to our cohort, higher WNK1 expression was significantly associated with unfavorable prognostic factors, such as high pT stage, pN stage, as well as shorter OS. Moreover, WNK1 exhibited tumor promoting role in COAD cancer cell lines as well as in nude mice. Silencing WNK1 can significantly inhibit the proliferation of COAD both in vitro and in vivo. CONCLUSIONS: In all, WNK1 acts as a tumor promoter and may be used as a COAD prognostic biomarker.
BACKGROUNDS: WNK1 (WNK lysine deficient protein kinase 1) is a kind of protein kinase and participates in angiogenesis, having a potent tumor promoting role. WNK1 is ubiquitously expressed, and its upregulated expression has been reported in several tumor types. AIMS: Here, we aimed to investigate the correlation between WNK1 expression and colon adenocarcinoma (COAD) progression. METHODS: In the current study, WNK1 expression was evaluated by immunohistochemically in adjacent normal colonic mucosae and primary adenocarcinomas. The effect of WNK1 on overall survival (OS) and its associations with the clinicopathological parameters were analyzed in a retrospective cohort of COAD patients (n = 185). The tumor-related effects of WNK1 in COAD were further tested via cellular and mice experiments. RESULTS: According to our cohort, higher WNK1 expression was significantly associated with unfavorable prognostic factors, such as high pT stage, pN stage, as well as shorter OS. Moreover, WNK1 exhibited tumor promoting role in COAD cancer cell lines as well as in nude mice. Silencing WNK1 can significantly inhibit the proliferation of COAD both in vitro and in vivo. CONCLUSIONS: In all, WNK1 acts as a tumor promoter and may be used as a COAD prognostic biomarker.
Authors: Hashem A Dbouk; Lauren M Weil; G K Sachith Perera; Michael T Dellinger; Gray Pearson; Rolf A Brekken; Melanie H Cobb Journal: Proc Natl Acad Sci U S A Date: 2014-10-31 Impact factor: 11.205
Authors: Brian R Haas; Vishnu A Cuddapah; Stacey Watkins; Katie Jo Rohn; Tiffany E Dy; Harald Sontheimer Journal: Am J Physiol Cell Physiol Date: 2011-08-03 Impact factor: 4.249
Authors: Peter Jun; Chibo Hong; Anita Lal; Judith M Wong; Michael W McDermott; Andrew W Bollen; Christoph Plass; William A Held; Dominic J Smiraglia; Joseph F Costello Journal: Neuro Oncol Date: 2008-11-11 Impact factor: 12.300